Select Medical Holdings Corp (SEM) FY2025Q2 Earning Prediction

07/31 04:00:00

After Hours

Select Medical Holdings Corp (SEM) is set to release its earnings performance on 07/31 04:00:00 in After Hours trading. Consensus forecasts predict a revenue of 1.35B and an earnings per share (EPS) of 0.28 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!

Estimate

Actual

Surprise

RevenueMISS

1.35B

1.34B

-0.66%

EPSBEAT

0.28

0.32

+14.29%

AI Summary

Earnings Surprise Analysis

The chart displays the extent of earnings surprises and corresponding stock price movements for each earnings event.

Revenue

EPS

SEM Transcript

Select Medical Holdings Corporation (SEM) Q3 2025 Earnings Call Transcript

Unknown10-31

Despite strong financial metrics and expansion plans, the lack of raised guidance due to outpatient segment softness and unchanged EBITDA guidance offset positive impacts. The Q&A revealed pressures from Medicare rates and payer mix shifts, which may concern investors. The market cap suggests moderate stock price movement. Thus, a neutral rating is appropriate.

Select Medical Holdings Corporation (SEM) Q2 2025 Earnings Call Transcript

Unknown8-1

The earnings call presents a mixed picture: strong revenue growth in some divisions, but challenges in critical illness recovery. The reaffirmed guidance and strategic focus on joint ventures are positive. However, regulatory issues and unclear management responses about critical illness impact cast doubts. The stock repurchase is a positive sign, but the debt level and margin declines in some areas are concerning. Given the market cap and mixed signals, a neutral stock price reaction is expected.

Select Medical Holdings Corporation (SEM) Q1 2025 Earnings Call Transcript

Unknown5-3

The earnings call revealed mixed financial performance with a decline in EBITDA and concerns over regulatory risks, particularly affecting LTAC. Despite positive growth in the Inpatient Rehab division and shareholder returns through dividends and stock repurchases, the company's high debt level and regulatory uncertainties pose significant risks. The Q&A highlighted management's unclear responses regarding mitigation strategies for regulatory impacts, adding to the negative sentiment. Given these factors and the market cap, a negative stock price movement is anticipated over the next two weeks.

Select Medical Holdings Corporation (NYSE:SEM) Q4 2024 Earnings Call Transcript

Unknown2-22

The earnings call presents a mixed outlook. Financial performance shows growth in revenue and EBITDA, but there are concerns with debt levels, declining margins in the inpatient rehab division, and operational challenges. The Q&A section highlights uncertainties, particularly around startup costs and margin impacts. Positive factors include revenue growth and optimistic guidance for new facilities, but high debt and lack of share repurchase are negative. Given the market cap, these mixed signals likely lead to a neutral stock price movement.

SEM Report

SELECT MEDICAL HOLDINGS CORP 10-K

10-K

2025-02-20

SELECT MEDICAL HOLDINGS CORP 10-Q

10-Q

2024-08-01

SELECT MEDICAL HOLDINGS CORP 10-Q

10-Q

2024-05-02

SELECT MEDICAL HOLDINGS CORP 10-K

10-K

2024-02-22

Frequently Asked Questions

What is the Select Medical Holdings Corp FY2025Q2 Earnings Release Date and Time?

Select Medical Holdings Corp (SEM) is scheduled to release its FY2025Q2 earnings report onJul 31, 2025, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.

What Are the Consensus Forecasts for Select Medical Holdings Corp FY2025Q2 Revenue and EPS?

Analysts' consensus predicts 1.35B in revenue and an EPS of 0.28 for Select Medical Holdings Corp's FY2025Q2.

What Does Intellectia's AI Predict for Select Medical Holdings Corp FY2025Q2 Earnings?

Intellectia's exclusive AI algorithms forecast a forSelect Medical Holdings Corp's FY2025Q2 earnings, with a prediction date of Jul 31, 2025. Select Medical Holdings Corp

How Can I Use This Earnings Prediction to Trade SEM Stock?

Leverage Intellectia's AI forecast to position trades ahead of theJul 31, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.

How Accurate Is Intellectia's AI for Earnings Predictions Like Select Medical Holdings Corp FY2025Q2?

Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.

How does AI Earnings Prediction generate its forecasts?

AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!

When are the predictions available, and how often are they updated?

Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.

Can I use AI Earnings Prediction for all types of stocks?

Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!